Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Inventory Average (2019 - 2025)

Historic Inventory Average for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to $9.0 billion.

  • Takeda Pharmaceutical's Inventory Average rose 1028.5% to $9.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.0 billion, marking a year-over-year increase of 1028.5%. This contributed to the annual value of $8.2 billion for FY2025, which is 439.55% up from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Inventory Average of $9.0 billion as of Q4 2025, which was up 1028.5% from $8.7 billion recorded in Q3 2025.
  • Takeda Pharmaceutical's Inventory Average's 5-year high stood at $9.0 billion during Q4 2025, with a 5-year trough of $6.7 billion in Q4 2022.
  • Moreover, its 5-year median value for Inventory Average was $7.8 billion (2023), whereas its average is $7.7 billion.
  • In the last 5 years, Takeda Pharmaceutical's Inventory Average crashed by 552.38% in 2022 and then surged by 1818.86% in 2023.
  • Takeda Pharmaceutical's Inventory Average (Quarter) stood at $7.1 billion in 2021, then decreased by 5.52% to $6.7 billion in 2022, then rose by 18.19% to $8.0 billion in 2023, then rose by 2.33% to $8.1 billion in 2024, then increased by 10.29% to $9.0 billion in 2025.
  • Its Inventory Average stands at $9.0 billion for Q4 2025, versus $8.7 billion for Q3 2025 and $8.3 billion for Q2 2025.